Document is current
Any future updates will be listed below
-
Authors
Suo, Daqin
Liang, Lily
Xia, Zengfei
Zhang, Ying
Zeng, Tingting
Li, Shuangjiang
Guan, Xin-Yuan
Li, Yan
-
Funding
Funding for this research was provided by:
Guangdong Esophageal Cancer Institute Science and Technology Program (Q202206, M202203)
National Natural Science Foundation of China (82473272)
Guangdong Basic & Applied Basic Research-Hybribio Joint Fund (2022A1515220091)
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 7 July 2025
First Online: 22 July 2025
Declarations
:
: The study was approved by the Committees for Ethical Review of Research Involving Human Subjects at SYSUCC with the number. G2023-075. This study was conducted following the ethical guidelines of the Declaration of Helsinki. All animal experiments were approved by the Animal Ethics Committee at SYSUCC with the number. L102012022228M.
: We confirm that all animal experiments were conducted in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines 2.0. A completed ARRIVE checklist has been included as Supplementary File to ensure transparent and comprehensive reporting of our study.
: The authors declare no competing interests.
